Clinical Trial Update: Electronic Study for Anastrozole Pharmacovigilance Evaluation

View source ↗

Summary

This document provides an update on a completed electronic pharmacovigilance study evaluating anastrozole for early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: Early Breast Cancer | Status: COMPLETED